Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 USD | +1.03% |
|
+4.24% | +18.00% |
28/06 | Transcript : OncoCyte Corporation - Shareholder/Analyst Call | |
18/06 | OncoCyte Names Andrea James Chief Financial Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.00% | 3.94Cr | |
-42.89% | 779.64Cr | |
+6.77% | 353.4Cr | |
-27.06% | 183.72Cr | |
-21.23% | 165.66Cr | |
+9.31% | 95Cr | |
+29.42% | 81Cr | |
-12.66% | 67Cr | |
-26.12% | 53Cr | |
+1.19% | 30Cr |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Earnings Flash (OCX) ONCOCYTE CORPORATION Posts Q4 Revenue $958,000, vs. Street Est of $1.42M